Organogenesis Holdings Inc. held its 2025 Annual Meeting of Stockholders on June 23, 2025. During the meeting, stockholders approved several proposals. These included the re-election of Garrett Lustig to the board of directors, the issuance of over 20% of outstanding Class A common stock upon conversion of Series A Convertible Preferred Stock, and the election of directors Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf, and Gilberto Quintero. All proposals were approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.